The aim of this study is to test the hypothesis that palifermin will be effective in the treatment of patients with acute lung injury (ALI). The trial objective is to undertaken a randomised double blind placebo controlled (i.e. dummy medication) clinical trial to study whether palifermin improves important surrogate markers of clinical outcome and is safe in adult patients with ALI in intensive care.